期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

O-甲基-α-羟基烃基膦酸酯单金属盐的合成及植物生长调节活性 被引量：1

Synthesis and Plant Growth Regulation Activity of O-Methyl-α-Hydroxyalkyl Phosphonate Monosalts
在线阅读 下载PDF
导出
摘要 合成了14个未见文献报道的O-甲基-α-羟基烃基膦酸酯单金属盐,通过IR1、H NMR和元素分析测试技术确证了它们的结构,并测定了它们的植物生长调节活性。生物测试结果表明,该类化合物对小麦和黄瓜具有不同程度的生长调节活性,其中化合物Ⅰk在10μg/g剂量下对黄瓜子根显示了较高的促进活性。 Fourteen new O-methyl-α-hydroxyalkyl phosphonate monosalts were synthesized and characterized by means of IR, ^1H NMR and elemental analysis. Their plant growth regulation activities for wheat and cucumber seedling were examined. The compound I k exhibits higher stimulating activity towards cucumber root growth at a dosage of 10 μg/g.
作者 廖桂红 贺红武
机构地区 华中师范大学化学学院有机合成研究所
出处 《应用化学》 CAS CSCD 北大核心 2005年第9期933-936,共4页 Chinese Journal of Applied Chemistry
基金 国家重点基础研究发展计划资助项目("九七三"计划)(2003CB114400) 国家自然科学基金资助项目(20072008 20372023)
关键词 α-羟基烷基膦酸酯单金属盐 合成 植物生长调节活性 α-hydroxyalkyl phosphonate monosalt,synthesis ,plant growth regulation activity
分类号 O627.1 [理学—有机化学]
  • 相关文献

参考文献13

二级参考文献39

  • 1贺红武,汪军,刘钊杰,万树青,陆爱红.具有生物活性的有机磷化合物的研究V，α－［（取代）芳氧基乙酰氧基］烷基膦酸酯的合成和性质[J].应用化学,1994,11(4):21-24. 被引量：22
  • 2Luckman SP,Coxon FP,Ebetino FH,et al.Heterocycle-containing bisphosphonates cause apoptosis and inhibit bone resorption by preventing protein prenylation:evidence from structure-activity relationships in J774 macrophages[J].J Bone Miner Res,1998,13(11):16
  • 3Dunford JE,Thompson K,Coxon FP,et al.Relationships for inhibition offarnesyl diphosphonate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates[J].J Pharm Exp Ther,2001,296(2):235-242.
  • 4Kotsikorou E,Oldfield E.A quantitative structure-activity relationship and pharmacophore modeling investigation of aryl-X and heterocyclic bisphosphonates as bone resorption agents[J].J Med Chem,2003,46(14):2932-2944.
  • 5Benford HL,Frith JC,Auriola S,et al.Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates:biochemical evidence for twodistinct pharmacological classes of bisphosphonate drugs[J].Mol Pharmacol,1999,56(1):131-140.
  • 6Auriola S,Frith J,Rogers MJ,et al.Identification of adenine nucleotide-containing metabolites of bisphosphonate drugs using ion-pair liquid chromatography-electrospray mass spectrometry[J].J Chrom:B,1997,704(1-2):187-195.
  • 7Frith JC,Monkkonen J,Blackburn GM,et al.Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analogue,adenosine 5′-(beta,gamma-dichloromethylene)triphosphate,by mammalian cells in vitro[J].J Bone Miner Res,1997,12(9):1358-1367.
  • 8Lehenkari PP,Kellinsalmi M,Napankangas JP,et al.Further insight intomechanism of action of clodronate:inhibition of mitochondrial ADP/ATP translocase by a nonhydrolyzable,adenine-containing metabolite[J].Mol Pharmacol,2002,61(5):1255-1262.
  • 9Luckman SP,Hughes DE,Coxon FP,et al.Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins,including Ras[J].J Bone Miner Res,1998,13(4):581-589.
  • 10Fisher JE,Rogers MJ,Halasy JM,et al.Alendronate mechanism of action:geranylgeraniol,an intermediate in the mevalonate pathway,prevents inhibition ofosteoclast formation,bone resorption and kinase activation in vitro[J].Proc Natl Acad Sci,1999,96(1):133-13

共引文献10

同被引文献6

引证文献1

二级引证文献2

应用化学
2005年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部